Clinical Trial Update: Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance [Phase 3]

View source ↗

Summary

Phase 3 add-on trial of ramelteon for sleep disturbance in bipolar I disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Insomnia

Drugs mentioned

• Ramelteon (Rozerem) (ramelteon)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Insomnia, Bipolar Disorder | Phase 3 | Status: TERMINATED